Human Genome Sciences Reports Positive Interim Results of Phase 2b ... - PR Newswire (press release)
April 15, 2007| Human Genome Sciences Reports Positive Interim Results of Phase 2b ... PR Newswire (press release), NY - The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. ... |